DelveInsight has launched a new report on the BK virus Infection Market
DelveInsight’s “BK virus (BKV) Infection – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the BK virus (BKV) Infection , historical and forecasted epidemiology as well as the BK virus (BKV) Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
BK virus (BKV) infection also known as polyomavirus is a member of the human polyomavirus family. BKV resides dormant in uroepithelial cells as it is mostly acquired in childhood and is not known to cause tissue damage in immunocompetent individuals. The virus can become reactivated in case of immunodeficiency (e.g., secondary to HIV infection or immunosuppressive medications), and result in cellular damage and organ dysfunction.
Request for free sample copy- https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-market
BK virus Infection detailed Market size by therapies, covering the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan from 2017-2030
BK virus (BKV) Infection Market Disease
The DelveInsight BK virus (BKV) Infection market report gives a thorough understanding of the BK virus (BKV) Infection by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.
BK virus (BKV) Infection Market Diagnosis
This segment of the report covers the detailed diagnostic methods or tests for BK virus (BKV) Infection.
BK virus Infection Treatment
Other treatment alternatives can include use of ciprofloxacin, rapamycin or intravenous immunoglobulin. Intravenous immunoglobulin (IVIG) is a non-depleting agent, with antiviral and immunomodulatory properties.
Key player of the report
BK virus Infection Market Insights
BK polyomavirus causes frequent infections during childhood and establishes persistent infections within renal tubular cells and the uroepithelium, with minimal clinical implications. BK polyomavirus (BKV) is a member of the Polyomaviridae family of double-stranded DNA (dsDNA) viruses. However, the reactivation of the infection of BKV in immunocompromised individuals following renal or hematopoietic stem cell transplantation may cause serious complications, including BKV-associated nephropathy (BKVAN), ureteric stenosis, or hemorrhagic cystitis.
BK virus Infection Market Size
The dynamics of BK virus (BKV) Infection market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies and incremental healthcare spending across the world. The launch of emerging therapies is expected during the forecast period of 2020–2030.
Owing to the positive outcomes of the some of the rare candidates during the developmental stage by key players, such as SL VAXiGEN (SL-V10), and others companies that are under preclinical phase of development have the potential to create a significant positive shift in BK virus infection in the market size.
BK virus (BKV) Infection Market Outlook
The BK virus (BKV) Infection market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted BK virus (BKV) Infection market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.
Table of content
1. Key Insights
2. Executive Summary of BK virus (BKV) Infection
3. Competitive Intelligence Analysis for BK virus (BKV) Infection
4. BK virus (BKV) Infection: Market Overview at a Glance
5. BK virus (BKV) Infection: Disease Background and Overview
6. Patient Journey
7. BK virus (BKV) Infection Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of BK virus (BKV) Infection Treatment
11. Marketed Products
12. Emerging Therapies
13. BK virus (BKV) Infection: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
15.1. United States: Market Size
16. Access and Reimbursement Overview of BK virus (BKV) Infection
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
BK virus Infection Market Report Highlights
Why should you buy this report?
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/